5, 6-D2 uridine nucleoside/tide derivatives
US10034893B2 · kind B2 · utility
33Cited by
11References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2014 |
| Grant date | Jul 31, 2018 |
| Priority date | — |
| Expiry date | Jan 22, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the invention provides compounds represented by Formula I, and pharmaceutically acceptable salts, esters, stereoisomers, tautomers, solvates, and combinations thereof, pharmaceutical compositions comprising these compounds and the use of these compounds for treating a viral infection in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.